EQUITY MARKET (25th Aug 2026)

FII/FPI & DII trading activity on NSE, BSE, and MSEI in Capital Market Segment 24^th Aug 2026

As of 10:58(IST)

NSE ADVANCE/DECLINE: 

As of 10:58(IST)

NIFTY INDEX DAILY REPORT

Nifty 50 index showcased strength, staging an impressive turnaround after shaking off morning declines. The market opened on a cautious note at 24,175.75 points, reflecting a drop from the preceding session’s close of 24,219.05, as investors initially proceeded with caution amid volatile derivative positioning and upcoming weekly options expirations. However, intense buying interest emerged during the final trading hour, triggering a rapid wave of short-covering across major sectors that carried the index all the way to its session high of 24,334.55. By the end of the day, the Nifty 50 locked in these peak gains, finishing the day up 115.50 points, or roughly 0.48%. From a technical perspective, this solid rebound above the psychologically important 24,300 mark underscores robust market sentiment and reaffirms strong underlying support around its key level of 24,006, providing a positive momentum foundation as the trading week progresses.

The Bank Nifty experienced a highly contested and structurally volatile trading session. The banking index initiated the day on a cautious note, opening with a gap down at 57,360.65, a noticeable retreat from the previous session’s closing mark of 57,525.95. This concerted upward push propelled the index to an intraday peak of 57,648.00. Unfortunately for the bulls, the heavy overhang of expiry-related position unwinding and aggressive contract squaring ultimately capped these gains, preventing any sustained afternoon breakout.Bank Nifty had settled into a slightly negative posture at 57,467.55, registering a marginal loss of 58.40 points.Crucially, holding above its 50-day moving average (57,200–57,250 support zone) leaves the underlying medium-term bullish structure intact.

Nifty Pharma index pulled off an impressive intraday recovery to finish solidly in the green. The healthcare sector started on a sluggish note, dipping early from its previous close of 26,339.30 to test support near the 26,160 mark. However, sustained buying in heavyweights like Sun Pharma and Dr. Reddy’s Laboratories effectively countered selling pressure seen in mid-tier formulation and active pharmaceutical ingredient (API) stocks. Technically, by bouncing off its 20-day exponential moving average and staying comfortably above the critical 50-day moving average (25,795), Nifty Pharma reinforced its broader bullish trend and cemented its role as a reliable safe-haven sector during choppy trading environments.

NIFTY DAILY CHART

The Nifty50 traded with positive momentum and managed to reach above the psychological level of 24,250 and settled at 24,334.55. This upside in the index has provided cushion to the nifty to reach 24,350-24,400. Else index may fizzle again to the level of 24,100, if it fails to sustain 24,250 level. However, fall in RSI is indicating pressure in the index. If RSI pulls  itself above 40, then we may see Nifty gaining momentum for the upside destination.

Equity Market Technical Analysis Snapshot: Aug 25^th, 2026

NIFTY50:

Nifty opened around 24,175.75 and witnessed selling pressure during the first half of the session, making a low of 24,115.45, before a strong recovery in the second half pushed the index higher to settle around 24,334.55. The trend has improved to sideways to bullish, with immediate resistance at 24,400 and 24,515, while support is placed at 24,250 and 24,100. Nifty remains below the 200-DMA but has reclaimed and is trading above the 30-DMA and 11-DMA, indicating improving short-term momentum. RSI at 52.39 has moved above the neutral zone, supporting a cautious bullish bias. A sustained breakout above 24,400 could further strengthen the recovery.

BANKNIFTY:

Bank Nifty opened around 57,360.65 and initially moved higher to 57,653.85 before witnessing selling pressure and declining to a low of 57,231.25. The index recovered from lower levels and settled around 57,514.20. The trend remains sideways, with resistance at 57,800 and 58,000, while support is placed at 57,100 and 56,900. Bank Nifty is trading below the 11-DMA and 30-DMA but remains above the 200-DMA, indicating a mixed technical setup. RSI at 50.37 is near neutral, suggesting that a decisive breakout above 58,000 or breakdown below 57,100 will be important for the next directional move.

NIFTY MID SELECT:

Nifty Mid Select opened around 14,885.55 and initially declined to a low of 14,834.35 before remaining range-bound and witnessing a strong recovery in the second half. The index settled higher around 15,000.90, reclaiming the important psychological and pivot level of 15,000. The trend remains bullish, with resistance at 15,080 and 15,250, while support is placed at 14,900 and 14,800. The index is trading above its 11-DMA, 30-DMA, and 200-DMA, confirming a positive technical structure. RSI at 60.51 indicates healthy bullish momentum, and sustained holding above 15,000 could support further upside.

NIFTY HEALTHCARE:

Nifty Healthcare opened around 16,410 and witnessed some initial volatility before moving higher, breaking above the 16,550 level and settling around 16,599.40. The trend remains bullish, with immediate resistance at 16,700 and 16,850, while support is placed at 16,550 and 16,300. The index is trading above its 11-DMA, 30-DMA, and 200-DMA, confirming a strong technical setup. RSI at 56.47 indicates positive but not overextended momentum, suggesting that the sector may continue to remain firm if it sustains above 16,550.

Pivot Table:

FII/FPI & DII trading activity on NSE, BSE, and MSEI in Capital Market Segment 25^th Aug 2026

Disclaimer:

Investment in securities markets is subject to market risks. Please read all related documents carefully before investing. (Our SEBI Reg. No. INH000010335)

AI Usage Disclosure: Artificial Intelligence (AI) tools were utilized exclusively for document formatting, structural layout, and presentation refinement.
All underlying research, financial analysis, forecasts, and investment recommendations are fully independent and conducted solely by the analyst(s).

For Full Disclaimer: Click Here